Reduced‐dose post‐transplant cyclophosphamide plus low‐dose post‐transplant anti‐thymocyte globulin as graft‐versus‐host disease prophylaxis with fludarabine–busulfan–cytarabine conditioning in haploidentical peripheral blood stem cell transplantation: A multicentre, randomized controlled clinical trial-Reference-Cited by-同舟云学术

Reduced‐dose post‐transplant cyclophosphamide plus low‐dose post‐transplant anti‐thymocyte globulin as graft‐versus‐host disease prophylaxis with fludarabine–busulfan–cytarabine conditioning in haploidentical peripheral blood stem cell transplantation: A multicentre, randomized controlled clinical trial

Published:2022-10-06 Issue:2 Volume:200 Page:210-221
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Zhang Wenli¹²^ORCID,Gui Ruirui¹^ORCID,Zu Yingling¹²^ORCID,Zhang Binglei¹²^ORCID,Li Zhen¹,Zhang Yanli¹,Wang Xianjing³^ORCID,Guo Shuli⁴^ORCID,Zhan Xinrong⁵^ORCID,Fu Yuewen¹,Song Yongping⁶^ORCID,Zhou Jian¹^ORCID

Affiliation:

1. Department of Hematology The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital Zhengzhou China

2. Academy of Medical Sciences Zhengzhou University Zhengzhou China

3. Department of Hematology The Third People's Hospital of Zhengzhou Zhengzhou China

4. Department of Hematology Luoyang Central Hospital Affiliated to Zhengzhou University Luoyang China

5. Department of Hematology Xinxiang Central Hospital Xinxiang China

6. Department of Hematology The First Affiliated Hospital of Zhengzhou University Zhengzhou China

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18483

Reference38 articles.

1. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies

2. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia

3. Who is the best donor for a related HLA haplotype-mismatched transplant?

4. Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

5. Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplants

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC;Bone Marrow Transplantation;2024-09-14

2. Cardiac Events Occurring after Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide. Study Conducted on Behalf of the GETH-TC;2024-07-26

3. Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study;Cancers;2024-07-17

4. Combination of Anti-thymocyte Globulin with Post-transplant Cyclophosphamide for GVHD Prophylaxis in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-analysis;Transplantation and Cellular Therapy;2024-07

5. Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation;Scientific Reports;2024-06-16